Bolt Biotherapeutics, Inc. - Common Stock (BOLT)
0.4901
-0.0128 (-2.55%)
Bolt Biotherapeutics is a biotechnology company that focuses on developing innovative immunotherapy treatments for cancer
The company utilizes its proprietary platform to create targeted therapies that engage the immune system to recognize and destroy cancerous cells more effectively. By harnessing the power of the body’s own immune response, Bolt aims to improve patient outcomes and provide new options for individuals battling various forms of cancer. Their research and development efforts are directed toward creating novel therapeutic candidates that can advance the field of cancer treatment.
Frequently Asked Questions
Is Bolt Biotherapeutics, Inc. - Common Stock publicly traded?
Yes, Bolt Biotherapeutics, Inc. - Common Stock is publicly traded.
What exchange does Bolt Biotherapeutics, Inc. - Common Stock trade on?
Bolt Biotherapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bolt Biotherapeutics, Inc. - Common Stock?
The ticker symbol for Bolt Biotherapeutics, Inc. - Common Stock is BOLT on the Nasdaq Stock Market
What is the current price of Bolt Biotherapeutics, Inc. - Common Stock?
The current price of Bolt Biotherapeutics, Inc. - Common Stock is 0.4901
When was Bolt Biotherapeutics, Inc. - Common Stock last traded?
The last trade of Bolt Biotherapeutics, Inc. - Common Stock was at 2:45 pm EST on January 31st, 2025
What is the market capitalization of Bolt Biotherapeutics, Inc. - Common Stock?
The market capitalization of Bolt Biotherapeutics, Inc. - Common Stock is 4.27M
How many shares of Bolt Biotherapeutics, Inc. - Common Stock are outstanding?
Bolt Biotherapeutics, Inc. - Common Stock has 8.71M shares outstanding.